Top Players in the Cell expansion Market and Strategies

-

According to research report the Cell Expansion Market is expected to reach USD 18.76 Billion by 2021 from USD 8.34 Billion in 2016 at a CAGR of 17.6% from 2016 to 2021. The report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the cell expansion market along with the estimates and forecasts of the revenue and market share analysis.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=194978883
The cell expansion market is consolidated in nature due to the presence of a few large players. The prominent players in the market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
Thermo Fisher Scientific Inc. (U.S.) was the global leader in the cell expansion market in 2015. It is a well-known company with an exhaustive product portfolio. The company is innovation-centric and invests heavily in R&D for maintaining its market share. Thermo Fisher Scientific mainly focuses on organic growth strategies such as new product launches for enhancing its share in the cell expansion market. The company also focuses on expansion for growth.
GE Healthcare (U.K.) held the second position in cell expansion market in 2015. Its high share in the market can be attributed to its strong portfolio of cell expansion products. The company mainly focuses on organic growth strategies, such as new product launches, for boosting its share in the market. For instance, it launched the Xuri Cell Expansion System W25 for the production of cellular immunotherapies in November 2013.
Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=194978883
The key strategies followed by most companies in the cell expansion market are new product launches; agreements and collaboration; mergers and acquisition; and expansion. New product launches accounted for the largest share of the overall strategic developments mapped in this report during 2013 to 2016. Some of the leading players that adopted this strategy include Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), and Thermo Fisher Scientific Inc. (U.S,). Agreements and collaborations accounted for the second-largest share of the overall growth strategies adopted by players in this market.

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more